(2R)-N-(4-phenoxybenzyl)-3-cyclohexylmethylthio-2-((4R)-3-(3-hydroxy-3-methylbutyryl)thiazolidin-4-ylcarbonylamino)propanamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2R)-N-(4-phenoxybenzyl)-3-cyclohexylmethylthio-2-((4R)-3-(3-hydroxy-3-methylbutyryl)thiazolidin-4-ylcarbonylamino)propanamide
• 英文别名: (4R)-N-[(2R)-3-(cyclohexylmethylsulfanyl)-1-oxo-1-[(4-phenoxyphenyl)methylamino]propan-2-yl]-3-(3-hydroxy-3-methylbutanoyl)-1,3-thiazolidine-4-carboxamide
• 化学式: C₃₂H₄₃N₃O₅S₂
• 分子量: 613.843
• InChiKey: GDCSVZRDLSCYCL-NSOVKSMOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  42
• 可旋转键数：
  13
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  159
• 氢给体数：
  3
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  N-羟基-7-氮杂苯并三氮唑 、 β-羟基异戊酸 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 (2R)-N-(4-phenoxybenzyl)-3-cyclohexylmethylthio-2-((4R)-thiazolidin-4-ylcarbonylamino)propanamide 在 碳酸氢钠 、 sodium chloride 作用下， 以 二氯甲烷 为溶剂， 生成 (2R)-N-(4-phenoxybenzyl)-3-cyclohexylmethylthio-2-((4R)-3-(3-hydroxy-3-methylbutyryl)thiazolidin-4-ylcarbonylamino)propanamide
  参考文献：
  名称：

  EP1097929

  摘要：

  公开号：

文献信息

• AMINO ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1097929A1

  公开（公告）日：2001-05-09

  The present invention relates to the compounds of the formula (I) and salts thereof (all the symbols are the same meanings as described in the specification). The compounds of the formula (I) possess inhibitory activity of N-type calcium channel, so they are useful as drug for prevention and/or treatment of cerebral infarct, transient ischemic attack, encephalomyelopathy after cardiac operation, spinal angiopathy, hypertension with stress, neurosis, epilepsy, asthma and pollakiuria etc. or agent for the treatment of pain.

  本发明涉及式（I）化合物及其盐类（所有符号的含义与说明书中所述相同）。 式（I）化合物具有抑制 N 型钙通道的活性，因此可作为预防和/或治疗脑梗塞、短暂性脑缺血发作、心脏手术后脑脊髓病变、脊髓血管病变、应激性高血压、神经官能症、癫痫、哮喘和花粉尿症等疾病的药物或治疗疼痛的制剂。
• Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them
  申请人：Seko Takuya

  公开号：US20050009890A1

  公开（公告）日：2005-01-13

  The present invention relates to the compounds of the formula (I) and salts thereof (all the symbols are the same meanings as described in the specification). The compounds of the formula (I) possess inhibitory activity of N-type calcium channel, so they are useful as drug for prevention and/or treatment of cerebral infarct, transient ischemic attack, encephalomyelopathy after cardiac operation, spinal angiopathy, hypertension with stress, neurosis, epilepsy, asthma and pollakiuria etc. or agent for the treatment of pain.
• US6903119B1
  申请人：——

  公开号：US6903119B1

  公开（公告）日：2005-06-07
• US7427634B2
  申请人：——

  公开号：US7427634B2

  公开（公告）日：2008-09-23
• EP1097929
  申请人：——

  公开号：——

  公开（公告）日：——